These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progressive hemifacial atrophy. A natural history study. Miller MT; Spencer MA Trans Am Ophthalmol Soc; 1995; 93():203-15; discussion 215-7. PubMed ID: 8719679 [TBL] [Abstract][Full Text] [Related]
4. The development of multiple ocular complications in a patient with Parry-Romberg syndrome. Keith TA; Tidmore E Clin Exp Optom; 2019 Jul; 102(4):437-439. PubMed ID: 30467888 [No Abstract] [Full Text] [Related]
5. [Parry-Romberg progressive facial hemiatrophy and localized scleroderma. Nosologic and pathogenic problems]. Auvinet C; Glacet-Bernard A; Coscas G; Cornelis P; Cadot M; Meyringnac C J Fr Ophtalmol; 1989; 12(3):169-73. PubMed ID: 2695557 [TBL] [Abstract][Full Text] [Related]
6. Interdisciplinary treatment and ophthalmological findings in Parry-Romberg syndrome. Dawczynski J; Thorwarth M; Koenigsdoerffer E; Schultze-Mosgau S J Craniofac Surg; 2006 Nov; 17(6):1175-6. PubMed ID: 17119425 [TBL] [Abstract][Full Text] [Related]
7. A case of progressive hemifacial atrophy with uveitis and retinal vasculitis. Ong K; Billson FA; Pathirana DS; Clifton-Bligh P Aust N Z J Ophthalmol; 1991 Nov; 19(4):295-8. PubMed ID: 1789967 [TBL] [Abstract][Full Text] [Related]